Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: Results from cancer and leukemia group B 9712 (CALGB 9712)

John C. Byrd, Bercedis L. Peterson, Vicki A Morrison, Kathleen Park, Robert Jacobson, Eva Hoke, James W. Vardiman, Kanti Rai, Charles A. Schiffer, Richard A. Larson

Research output: Contribution to journal › Article › peer-review

522 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: Results from cancer and leukemia group B 9712 (CALGB 9712)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds